Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus clausii for prevention of antibiotic-associated diarrhea in Filipino infants and children
2014-004629-42Phase 4
- Sponsor
- Sanofi
- Start
- Apr 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bacillus clausii in antibiotic-associated diarrhea (AAD) and acute diarrhea (2 arms), sponsored by Sanofi. Primary endpoint: Number of antibiotic-associated diarrhea events.
02
Drugs
bacillus clausii
03
Conditions
antibiotic-associated diarrhea (AAD)acute diarrhea
Beyond the preview
Go deeper on 2014-004629-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004629-42.